|
|
|
18 Aug 2008 |
SymBio Pharmaceuticals and Eisai Sign License Agreement for bendamustine hydrochloride (SyB L-0501)
|
|
16 Aug 2008 |
Cytos Biotechnology and Pfizer enter into a research, option and license agreement for certain novel vaccines for a defined number of human diseases
|
|
14 Aug 2008 |
Abbott and AstraZeneca expand relationship to include co-promotion of CRESTOR(R)
|
|
13 Aug 2008 |
Diakron Licenses Anticoagulant Drug Candidate from Merck & Co., Inc. Orchid Pharma partners with Diakron
|
|
13 Aug 2008 |
ImmunoGen, Inc. Announces sanofi-aventis Licenses Expanded Access to the Company's TAP Technology
|
|
07 Aug 2008 |
Ore Pharmaceuticals Acquires Rights to Develop a Second Drug Candidate from Roche
|
|
07 Aug 2008 |
Nycomed successfully closes oncology program
|
|
31 Jul 2008 |
Ore Pharmaceuticals Acquires Repositioned Clinical-Stage Drug Candidate from Roche
|
|
31 Jul 2008 |
MediGene Sells Licensee Rights To The Drug Oracea(R) To Galderma
|
|
30 Jul 2008 |
Cytochroma and Mitsubishi Tanabe Form Partnership for Chronic Kidney Disease Therapies in U.S. and Asia
|
|
28 Jul 2008 |
Ambrilia Provides Update on PPL-100 Partnership With Merck & Co, Inc.
|
|
23 Jul 2008 |
MorphoSys Licenses RapMAT Technology to Astellas
|
|
23 Jul 2008 |
Merck Receives European Approval for Broader Use of Erbitux in Metastatic Colorectal Cancer Including First-Line Treatment
|
|
22 Jul 2008 |
Dyax Corp. and AVEO Pharmaceuticals Announce Antibody Library License Agreement
|
|
22 Jul 2008 |
BioMarin and Summit plc Sign Worldwide Licensing Agreement for Duchenne Muscular Dystrophy Program
|
|
17 Jul 2008 |
MediGene exercises option for Anti-L1 Monoclonal Antibody and continues collaboration with DKFZ (German Cancer Research Center)
|
|
17 Jul 2008 |
Boehringer Ingelheim licenses drug targets from autoimmune collaboration with BioFocus DPI
|
|
17 Jul 2008 |
Genzyme Corporation and PTC Therapeutics Announce Collaboration on Small Molecule for Genetic Disease
|
|
16 Jul 2008 |
BioWa and Medarex Announce License of BioWa's COMPLEGENT(TM) Technology
|
|
15 Jul 2008 |
Dyax Enters into an Exclusive Negotiation Period with Dompe for European License to DX-88 in Angioedema Indications
|
|
14 Jul 2008 |
GlaxoSmithKline and Actelion enter into exclusive collaboration to realise the full potential of almorexant in sleep disorders and beyond
|
|
14 Jul 2008 |
Nycomed adds veltuzumab for autoimmune diseases to R&D pipeline
|
|
10 Jul 2008 |
Altus Pharmaceuticals Secures Long-Term Growth Hormone Supply For ALTU-238 Clinical Development and Commercialization
|
|
10 Jul 2008 |
ValiRx Plc Acquires Global Rights to Novel Compound Targeted at Prostate Cancer
|
|
10 Jul 2008 |
Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
|
|
09 Jul 2008 |
Fresenius Medical Care Signs Agreements for Intravenous Iron Products
|
|
06 Jul 2008 |
Sentek Announces Termination of Invicorp(R) Licensse Agreement With Ardana Bioscience Limited
|
|
03 Jul 2008 |
ARYx Therapeutics, Inc. Announces Procter & Gamble Exercises Option to End Collaboration on ATI-7505
|
|
23 Jun 2008 |
OVATION Pharmaceuticals To In-License ATryn(R) (antithrombin alfa) in the United States
|
|
23 Jun 2008 |
Emisphere Announces License Agreement With Novo Nordisk to Develop Oral Formulation of GLP-1 Receptor Agonists for Diabetes
|
|
19 Jun 2008 |
Alnylam and Kyowa Hakko Form Alliance for the Development and Commercialization of ALN-RSV01 in Asia
|
|
18 Jun 2008 |
Nile Therapeutics Completes License Agreement for CU-NP, a Rationally Designed Natriuretic Peptide
|
|
18 Jun 2008 |
ThromboGenics and BioInvent announce a strategic alliance with Roche for TB-403, a novel anti-cancer antibody
|
|
12 Jun 2008 |
NOXXON Pharma AG Announces Licensing and Discovery Collaboration with Eli Lilly and Company
|
|
12 Jun 2008 |
Lilly and TransPharma Medical Announce Licensing and Development Agreement
|
|
12 Jun 2008 |
OPKO Acquires Rights to Novel Phase II Agent to Treat Viral Conjunctivitis
|
|
10 Jun 2008 |
Otsuka and UCB agreed to co-develop and co-promote Keppra(R) and Cimzia(R) in Japan
|
|
10 Jun 2008 |
Mylan Inc., NATCO Pharma Ltd. To Collaborate on Worldwide Marketing and Distribution of Generic Copaxone(R)
|
|
08 Jun 2008 |
WILEX and IBA enter into worldwide marketing, distribution and sales agreement on REDECTANE(R) (CA9-SCAN)
|
|
05 Jun 2008 |
Anesiva and Transcription Factor Therapeutics, Inc. Announce Licensing Agreement for Development and Commercialization of NF-kappa B Clinical Program
|
|
03 Jun 2008 |
Amira Pharmaceuticals achieves milestones in FLAP inhibitor program with GlaxoSmithKline
|
|
30 May 2008 |
Gilead and Navitas Announce Agreement for Cicletanine for the Treatment of Pulmonary Arterial Hypertension
|
|
30 May 2008 |
Nuvo licenses topical pain product from Paladin
|
|
30 May 2008 |
Orion receives rights for incontinence drug Kentera(R) from Recordati
|
|
28 May 2008 |
4SC and ViroLogik conclude a licensing and cooperation agreement
|
|
27 May 2008 |
Inovio Biomedical Licenses Electroporation Delivery Technology to Leading U.S. Government Contractor, Advanced BioScience Laboratories, Inc.
|
|
13 May 2008 |
Bristol-Myers Squibb and KAI Pharmaceuticals Enter Global Alliance to Develop and Commercialize KAI-9803 for Cardiovascular Disease
|
|
12 May 2008 |
Theratechnologies and PDC Biotech GmbH sign license agreement for family of peptides for Preterm Labour and Primary Dysmenorrhea programs
|
|
07 May 2008 |
Par Pharmaceutical acquires Spectrum Pharmaceutical's interest in Sumatriptan Injection
|
|
02 May 2008 |
Biosimilar G-CSF: Cooperation on Three Continents.
|
| |
|
Results 1 - 50 of 751 |
